Logo
x

Search

Subscribe Now

People

Eli Lilly's Verzenio (abemaciclib) Receives the US FDA's Approval for People with HR+ HER2- High Risk Early Breast Cancer

Eli Lilly's Verzenio (abemaciclib) Receives the US FDA's Approval for People with HR+ HER2- High Risk Early Breast Cancer

  • October 13, 2021
Zealand's Zegalogue (dasiglucagon) Receives the US FDA's Approval for the Treatment of Severe Hypoglycemia

Zealand's Zegalogue (dasiglucagon) Receives the US FDA's Approval for the Treatment of Severe Hypoglycemia

  • March 24, 2021
Genentech Reports Two-Year Data of Evrysdi (risdiplam) for People with Type 2 or Type 3 SMA

Genentech Reports Two-Year Data of Evrysdi (risdiplam) for People with Type 2 or Type 3 SMA

  • March 16, 2021
Celltrion Receives Health Canada's Approval for Remsima SC (biosimilar- infliximab) for Rheumatoid Arthritis

Celltrion Receives Health Canada's Approval for Remsima SC (biosimilar- infliximab) for Rheumatoid Arthritis

  • February 2, 2021
Roche Reports Long-Term Benefits of Venclexta/Venclyxto Based Combination for R/R Chronic Lymphocytic Leukemia

Roche Reports Long-Term Benefits of Venclexta/Venclyxto Based Combination for R/R Chronic Lymphocytic Leukemia

  • December 7, 2020
Lilly Signs Agreement with Ypsomed to Advance an Automated Insulin Delivery System for People with Diabetes

Lilly Signs Agreement with Ypsomed to Advance an Automated Insulin Delivery System for People with Diabetes

  • November 20, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.